Find the right fit for you - faster
Get tailored insights about working at AtomVie Global Radiopharma in one quick step.
AtomVie Global Radiopharma Snapshot
PharmaceuticalIndustry
Transforming lives by revolutionizing healthcare.
Empowering Next Generation Radiotherapeutics
AtomVie Global Radiopharma Inc. ("AtomVie"), incorporated in late 2021, is a global leading CDMO for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals and the most recent spinout from the Centre for Probe Development and Commercialization (CPDC). It offers the full range of scientific, technical, regulatory, quality, logistics and business expertise combined with a specialized infrastructure for the development of your radiopharmaceuticals from Phase 1 to the commercial marketplace. With a State-of-the art purpose-built facility that will be operational in 2024, AtomVie empowers the development of your radiotherapeutics.
For more information about AtomVie, visit www.atomvie.com or contact: info@atomvie.com.
AtomVie Global Radiopharma Inc. ("AtomVie"), incorporated in late 2021, is a global leading CDMO for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals and the most recent spinout from the Centre for Probe Development and Commercialization (CPDC). It offers the full range of scientific, technical, regulatory, quality, logistics and business expertise combined with a specialized infrastructure for the development of your radiopharmaceuticals from Phase 1 to the commercial marketplace. With a State-of-the art purpose-built facility that will be operational in 2024, AtomVie empowers the development of your radiotherapeutics.
For more information about AtomVie, visit www.atomvie.com or contact: info@atomvie.com.
